AHA GUIDELINES Bundle (free trial)

Dyslipidemia 2026

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1543908

Contents of this Issue

Navigation

Page 63 of 105

64 Management Figure 13. Managing Adults With Subclinical Atherosclerosis CAC = 1 to 99 AU and <75th percentile for age, sex, race Management of patients with subclinical atherosclerosis Severe: CAC ≥300 to 999 AU Optional apoB goal <70 mg/dL Optional apoB goal <55 mg/dL CAC ≥100 to 299 AU or ≥75th percentile for age, sex, race 2a Start moderate- intensity statin Goal: ≥30%–49% LDL-C reduction; LDL-C <100 mg/dL and non–HDL-C <130 mg/dL 1 Start LDL–C- lowering therapy Goal: ≥50% LDL-C reduction; LDL-C <70 mg/dL and non–HDL-C <100 mg/dL 1 Start LDL–C- lowering therapy Goal: ≥50% LDL-C reduction; LDL-C <70 mg/dL and non–HDL-C <100 mg/dL 2a Optional goal: LDL-C of <55 mg/dL and non–HDL-C <85 md/dL apoB indicates apolipoprotein B; AU, Agatston Units; CAC, coronary artery calcium; CT, computed tomography; HDL-C, high-density lipoprotein-cholesterol; and LDL-C, low-density lipoprotein-cholesterol.

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Dyslipidemia 2026